Sittings · Compare

What changed

From · resolution motion · 2024-10-25 B-10-2024-0153 on the draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified MON 94804, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council
To · Adopted text · 2024-11-26 TA-10-2024-0045 Genetically modified maize MON 94804
+4 added · −2 removed · 2 modified paragraphs

B100153/2024

P10_TA(2024)0045

European Parliament resolution on the draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified MON 94804 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (D099729/02 – 2024/2841(RSP))

Genetically modified maize MON 94804

PE763.294

European Parliament resolution of 26 November 2024 on the draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified maize MON 94804 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (D099729/02 – 2024/2841(RSP))

The European Parliament,

– having regard to the draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified maize MON 94804 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (D099729/02),

– having regard to Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modified food and feed, and in particular Article 7(3) and Article 19(3) thereof,

A. whereas on 14 February 2023, Bayer Agriculture BV, based in Belgium, submitted on behalf of Bayer CropScience LP, based in the United States, an application to the national competent authority of the Netherlands for the placing on the market of foods, food ingredients and feed containing, consisting of or produced from genetically modified maize MON 94804 (the ‘GM maize’), in accordance with Articles 5 and 17 of Regulation (EC) No 1829/2003 (‘the application’);

B. whereas the application also covered the placing on the market of products containing or consisting of geneticallythe modifiedGM maize MON 94804 for uses other than food and feed, with the exception of cultivation;

C. whereas, on 13 March 2024, EFSA adopted a favourable opinion, which was published on 26 April 2024, concluding that the GM maize is as safe as its conventional counterpart and the tested non-GM maize varieties with respect to potential effects on human and animal health and the environment;